India's first indigenous biologic, Biocon's ALZUMAb gets approval for COVID-19 treatment

India's first indigenous biologic, Biocon's ALZUMAb gets approval for COVID-19 treatment: Following the news that India-based biopharma company Biocon’s plaque psoriasis drug itolizumab (ALZUMAb) has secured approval from the Drugs Controller General of India (DCGI) for emergency use in COVID-19 patients;

VARINDIA- INDIA'S FRONTLINE IT MAGAZINE

Comments

Popular posts from this blog

PhysicsWallah transitions to public entity in preparation for 2025 IPO

OpenAI unveils new o3 and o3 mini models, set for 2024 launch